QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

LGND

QT77Ligand Pharmaceuticals Incorporated
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
274.88
+11.74+4.46%
OverviewShort InterestFilings
LGNDQT77Ligand Pharmaceuticals Incorporated·NASDAQ
OverviewShort InterestFilings
274.88+4.46%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E34.07EPS (ttm)
7.37
Insider Own-
Shs Outstand-
Perf Week7.98%
Market Cap5.27BForward P/E24.70EPS next Y11.13Insider Trans-Shs Float-Perf Month32.29%
Enterprise Value5.61BPEG0.03EPS next Q1.97Inst Own-Short Float-Perf Quarter30.59%
Income154.52MP/S19.21EPS this Y22.90%Inst Trans-Short Ratio-Perf Half Y42.70%
Sales274.48MP/B5.25EPS next Y22.87%ROA10.02%Short Interest-Perf YTD45.39%
Book/sh-P/C42.39EPS next 5Y16.49%ROE16.19%52W High276.21 -0.48%Perf Year144.25%
Cash/sh-P/FCF42.89EPS past 3/5Y-ROIC5.61%52W Low110.00 149.89%Perf 3Y-
Dividend Est.-EV/EBITDA25.25Sales past 3/5Y10.99% 10.32%Gross Margin98.61%Volatility2.25% 2.32%Perf 5Y-
Dividend TTM-EV/Sales20.44EPS Y/Y TTM3890.91%Oper. Margin36.72%ATR (14)8.79Perf 10Y-
Dividend Ex-DateJul 02, 2010Quick Ratio20.95Sales Y/Y TTM64.67%Profit Margin55.95%RSI (14)80.26Recom2.00
Dividend Gr. 3/5Y-63.47% -Current Ratio21.28EPS Q/Q22.56%SMA2013.47%Beta0.95Target Price265.33
Payout0.00%Debt/Eq0.45Sales Q/Q15.56%SMA5019.13%Rel Volume2.68Prev Close263.14
Employees68LT Debt/Eq0.44EarningsAug 06SMA20036.48%Avg Volume227.23KPrice274.88
IPO DateNov 18, 1992Option/ShortYes / YesEPS/Sales Surpr.-11.41% -11.86%Net Debt/EBITDA1.52Volume609,561Change4.46%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-30-26ReiteratedH.C. WainwrightBuy$243 → $289
Apr-28-26ReiteratedRBC CapitalOutperform$130 → $252
Apr-27-26ReiteratedStifel Nicolaus$230 → $255
Apr-14-26ReiteratedH.C. WainwrightBuy$239 → $243
Feb-24-26ReiteratedH.C. WainwrightBuy$231 → $239
Dec-10-25ReiteratedStifel Nicolaus$220 → $230
Dec-10-25ReiteratedOppenheimerOutperform$250 → $275
Nov-06-25ReiteratedStifel Nicolaus$220
Nov-06-25ReiteratedH.C. WainwrightBuy$206 → $231
Nov-03-25ReiteratedOppenheimerOutperform$190 → $250
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue275268167
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A4711
Gross Profit272261156
Selling, General and Administrative Excl. Other949279
Research and Development348121
Other Operating Expense424179
Operating Income10047-23
Interest Expense553
Unusual Expense
———
Non-Operating Income (Expense)-87-112-28
Net Income Before Taxes1851593
Income Taxes31357
Consolidated Net Income154124-4
Net Income From Continuing Operations154124-4
Net Income154124-4
EPS (Recurring)7.846.44-0.22
EPS (Basic, Before Extraordinaries)7.846.44-0.22
EPS (Diluted)7.376.13-0.22
EBITDA22219341
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio37.3030.84—
Price To Sales Ratio19.9913.40—
Gross Margin98.9197.3993.41
Operating Margin36.3617.54-13.77
Net Margin56.0046.27-2.40
Shares Outstanding201918
Market Capitalization5,4983,592—
Operating Lease Expense
———
Insider Trading Volume
$314.07$288.77$263.47$238.17$212.87● Close Price0.00M1.43M2.87M4.30M5.73MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Sabba Stephen LDirectorJun 16 '26Option Exercise66.134,290283,69835,774Jun 18 12:00 AM
Sabba Stephen LDirectorJun 16 '26Sale254.002,145544,83033,629Jun 18 12:00 AM
Haas JasonDirectorJun 12 '26Sale255.586,4611,651,3204,981Jun 15 12:00 AM
Haas JasonDirectorJun 12 '26Option Exercise51.568,000412,48011,442Jun 15 12:00 AM
Aryeh JasonDirectorJun 11 '26Sale250.004,5001,125,000102,580Jun 12 12:00 AM
Aryeh JasonDirectorJun 10 '26Sale250.00500125,000107,080Jun 12 12:00 AM
LAMATTINA JOHN LDirectorJun 10 '26Sale250.884,5911,151,77426,969Jun 12 12:00 AM
Reardon AndrewCLO & SecretaryJun 01 '26Sale227.065,0001,135,31641,382Jun 02 12:00 AM
Reardon AndrewCLO & SecretaryJun 01 '26Option Exercise52.2710,000522,70046,382Jun 02 12:00 AM
Espinoza OctavioChief Financial OfficerMay 27 '26Option Exercise57.583,472199,93227,679May 28 12:00 AM
KOZARICH JOHN WDirectorMay 13 '26Option Exercise69.513,150218,95643,361May 14 12:00 AM
KOZARICH JOHN WDirectorMay 13 '26Sale223.501,575352,01341,786May 14 12:00 AM
KOZARICH JOHN WDirectorMay 12 '26Sale224.00459102,81641,786May 14 12:00 AM
KOZARICH JOHN WDirectorMay 12 '26Option Exercise69.5191863,81042,245May 14 12:00 AM
KOZARICH JOHN WDirectorMay 01 '26Sale231.80467108,25141,786May 14 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR